China Diabetes Drugs Market Size is Anticipated to Reach USD 21.22 Billion by 2035, Growing at a CAGR of 6.31% from 2025 to 2035. China diabetes drug market is driven by factors such as an aging population, increasing obesity rates, earlier disease onset, growing adoption of GLP-1 and dual-agonist therapies, expansion of digital prescription channels, strong venture funding, a robust biosimilar pipeline, and investment from multinational companies.